Table 3.
List of native-kidney biopsy diagnoses that are used to identify patients eligible for registration in the BC GN Registry
| Histologic diagnoses enrolled in the BC GN registry | |
|---|---|
| Alport’s disease |
Idiopathic nodular glomerulosclerosis |
| Amyloidosis: AL |
IgA nephropathy |
| Amyloidosis: AA |
IgM nephropathy |
| Amyloidosis: other |
Immunotactoid GN |
| Anti-GBM antibody (Goodpasture’s) GN |
Light chain deposition disease |
| Autoimmune/connective tissue disease associated GN |
Light and heavy chain deposition disease |
| Cryoglobulinemic GN |
Lupus nephritis |
| C3 GN |
Minimal change disease |
| C1q nephropathy |
Membranoproliferative GN, complement mediated |
| Dense deposit disease |
Membranoproliferative GN, IC mediated |
| Fabry’s disease |
Membranous nephropathy |
| Fibrillary GN |
Mesangial proliferative GN |
| Focal segment glomerulosclerosis |
Pauci-immune (ANCA) GN |
| GN with monoclonal immunoglobulin deposits |
Post-infectious GN |
| GN not otherwise specified |
Proliferative GN |
| Heavy chain deposition disease |
Thin basement membrane disease |
| Henoch-Schonlein purpura | Waldenstrom’s macroglobulinemia |
This list may be updated in the future as histologic classifications change over time.